title: Clinical Inquiries. How can we best treat and monitor VTE during pregnancy?
authors.affiliation: Valley Family Medicine Residency, Renton, Washington, USA.
authors.forename: Danielle
authors.initials: D
authors.lastname: Debelak
authors.forename: Jon O
authors.initials: JO
authors.lastname: Neher
authors.forename: Leilani
authors.initials: L
authors.lastname: St Anna
authors.forename: Linda
authors.initials: L
authors.lastname: French
mesh_terms: D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D035002:Lower Extremity / Q000098:blood supply* / Q000473:pathology*; D008429:Maternal Welfare; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis* / Q000188:drug therapy*; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000628:therapy; D020246:Venous Thrombosis / Q000175:diagnosis* / Q000188:drug therapy*
chemical_list: D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight